NO871526L - Tiolaktam-n-eddiksyrederivater og fremgangsmaate for deres fremstilling. - Google Patents
Tiolaktam-n-eddiksyrederivater og fremgangsmaate for deres fremstilling.Info
- Publication number
- NO871526L NO871526L NO871526A NO871526A NO871526L NO 871526 L NO871526 L NO 871526L NO 871526 A NO871526 A NO 871526A NO 871526 A NO871526 A NO 871526A NO 871526 L NO871526 L NO 871526L
- Authority
- NO
- Norway
- Prior art keywords
- tiolactam
- procedures
- preparation
- acetic acid
- acid derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8929586 | 1986-04-17 | ||
JP14594186 | 1986-06-20 |
Publications (4)
Publication Number | Publication Date |
---|---|
NO871526D0 NO871526D0 (no) | 1987-04-10 |
NO871526L true NO871526L (no) | 1987-10-19 |
NO167916B NO167916B (no) | 1991-09-16 |
NO167916C NO167916C (no) | 1991-12-27 |
Family
ID=26430721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO871526A NO167916C (no) | 1986-04-17 | 1987-04-10 | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiolaktam-n-eddiksyrederivater |
Country Status (19)
Country | Link |
---|---|
US (1) | US4771050A (no) |
EP (1) | EP0243018B1 (no) |
JP (1) | JPS63107970A (no) |
KR (1) | KR870010024A (no) |
CN (1) | CN1020098C (no) |
AR (1) | AR244674A1 (no) |
AU (1) | AU602641B2 (no) |
CA (1) | CA1287629C (no) |
DE (1) | DE3765682D1 (no) |
DK (1) | DK184587A (no) |
ES (1) | ES2022889B3 (no) |
FI (1) | FI89711C (no) |
GR (1) | GR3001210T3 (no) |
HK (1) | HK108293A (no) |
HU (1) | HU198699B (no) |
IE (1) | IE60246B1 (no) |
NO (1) | NO167916C (no) |
PT (1) | PT84704B (no) |
SU (1) | SU1538895A3 (no) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2996475B2 (ja) * | 1989-12-22 | 1999-12-27 | サントリー株式会社 | ベンズオキサジノン誘導体及びそれを有効成分として含有する除草剤 |
TW200402B (no) * | 1990-08-13 | 1993-02-21 | Senju Pharma Co | |
AU638154B2 (en) * | 1990-10-04 | 1993-06-17 | Suntory Limited | Benzoxazine derivative and herbicide containing same as an active ingredient |
IE914455A1 (en) * | 1990-12-27 | 1992-07-01 | Green Cross Corp | 1,4-benzothiazine-2-acetic acid derivatives, processes for production thereof |
EP0627425B1 (en) * | 1992-08-31 | 2000-11-02 | Santen Pharmaceutical Co., Ltd. | 3-oxo-1,4-benzothiazine derivative |
JP3126541B2 (ja) * | 1993-03-26 | 2001-01-22 | 千寿製薬株式会社 | ベンゾチアゾール誘導体、その製法及びその用途 |
WO1995013269A1 (fr) * | 1993-11-12 | 1995-05-18 | Santen Pharmaceutical Co., Ltd. | Derive de 1,4-benzothiazine |
SG120054A1 (en) * | 1997-04-15 | 2006-03-28 | Csir | Appetite suppressant steroidal glycosides |
GB2355657B (en) * | 1999-10-27 | 2004-07-28 | Phytopharm Plc | Inhibitors Of Gastric Acid Secretion |
US6713477B1 (en) | 2000-04-19 | 2004-03-30 | Sumitomo Pharmaceuticals Company, Limited | Hydroxamic acid derivatives |
GB2363985B (en) | 2000-06-30 | 2004-09-29 | Phytopharm Plc | Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use |
CZ20031387A3 (cs) | 2000-11-30 | 2004-04-14 | Pfizer Products Inc. | Farmaceutický prostředek, kterým je směs agonistů gama-aminomáselné kyseliny a inhibitorů aldózreduktázy |
WO2005082872A1 (ja) * | 2004-03-02 | 2005-09-09 | Dainippon Sumitomo Pharma Co., Ltd. | ベンゾチアジン-3-オン化合物及びその製造中間体 |
US20110092566A1 (en) * | 2004-11-19 | 2011-04-21 | Srivastava Satish K | Treatment of cancer with aldose reductase inhibitors |
US20070197512A1 (en) * | 2006-01-27 | 2007-08-23 | Japan Tobacco Inc. | Carboxylic Acid Compounds and Use Thereof |
EP1985297A1 (en) * | 2006-01-27 | 2008-10-29 | Japan Tobacco, Inc. | Carboxylic acid compound and use thereof |
JP2010520913A (ja) | 2007-03-12 | 2010-06-17 | サズセ アーペーエス | ルイボスの抗糖尿病性抽出物 |
AU2008230949B2 (en) | 2007-03-23 | 2013-05-30 | The Board Of Regents Of The University Of Texas System | Methods involving aldose reductase inhibitors |
US20090270490A1 (en) * | 2008-04-24 | 2009-10-29 | The Board Of Regents Of The University Of Texas System | Methods involving aldose reductase inhibition |
AU2011348074B2 (en) | 2010-12-23 | 2016-04-28 | The Board Of Regents Of The University Of Texas System | Methods for treating COPD |
US12090142B2 (en) | 2018-02-22 | 2024-09-17 | Board Of Regents, The University Of Texas System | Combination therapy for the treatment of cancer |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1173942A (en) * | 1967-06-06 | 1969-12-10 | Bellon Labor Sa Roger | New 2,3-Dihydro-1,4-Benzoxazines |
US3923709A (en) * | 1974-08-30 | 1975-12-02 | Monsanto Co | 3,4-Dihydro-3-oxo-2H-1,4-benzothiazines and benzoxazines |
IE58312B1 (en) * | 1984-05-18 | 1993-09-08 | Union Pharma Scient Appl | Heterocyclic derivatives, processes for their preparation and drugs in which they are present, which are useful especially as aldose reductase inhibitors |
-
1987
- 1987-03-27 AU AU70730/87A patent/AU602641B2/en not_active Ceased
- 1987-04-01 ES ES87302825T patent/ES2022889B3/es not_active Expired - Lifetime
- 1987-04-01 DE DE8787302825T patent/DE3765682D1/de not_active Expired - Fee Related
- 1987-04-01 EP EP87302825A patent/EP0243018B1/en not_active Expired - Lifetime
- 1987-04-10 NO NO871526A patent/NO167916C/no unknown
- 1987-04-10 DK DK184587A patent/DK184587A/da not_active Application Discontinuation
- 1987-04-13 US US07/037,785 patent/US4771050A/en not_active Expired - Fee Related
- 1987-04-15 AR AR87307299A patent/AR244674A1/es active
- 1987-04-16 IE IE101287A patent/IE60246B1/en not_active IP Right Cessation
- 1987-04-16 FI FI871719A patent/FI89711C/fi not_active IP Right Cessation
- 1987-04-16 PT PT84704A patent/PT84704B/pt not_active IP Right Cessation
- 1987-04-16 CN CN87102891A patent/CN1020098C/zh not_active Expired - Fee Related
- 1987-04-16 HU HU871690A patent/HU198699B/hu not_active IP Right Cessation
- 1987-04-16 SU SU874202416A patent/SU1538895A3/ru active
- 1987-04-16 CA CA000534940A patent/CA1287629C/en not_active Expired - Lifetime
- 1987-04-17 JP JP62096000A patent/JPS63107970A/ja active Granted
- 1987-04-17 KR KR870003700A patent/KR870010024A/ko not_active Application Discontinuation
-
1990
- 1990-12-18 GR GR90401083T patent/GR3001210T3/el unknown
-
1993
- 1993-10-14 HK HK1082/93A patent/HK108293A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PT84704B (pt) | 1989-11-30 |
CN1020098C (zh) | 1993-03-17 |
NO871526D0 (no) | 1987-04-10 |
JPH034550B2 (no) | 1991-01-23 |
US4771050A (en) | 1988-09-13 |
HUT45515A (en) | 1988-07-28 |
NO167916C (no) | 1991-12-27 |
DE3765682D1 (de) | 1990-11-29 |
PT84704A (en) | 1987-05-01 |
HU198699B (en) | 1989-11-28 |
NO167916B (no) | 1991-09-16 |
DK184587A (da) | 1987-10-18 |
IE60246B1 (en) | 1994-06-15 |
AR244674A1 (es) | 1993-11-30 |
ES2022889B3 (es) | 1991-12-16 |
AU7073087A (en) | 1987-10-22 |
CA1287629C (en) | 1991-08-13 |
EP0243018B1 (en) | 1990-10-24 |
SU1538895A3 (ru) | 1990-01-23 |
EP0243018A1 (en) | 1987-10-28 |
FI89711C (fi) | 1993-11-10 |
FI871719A (fi) | 1987-10-18 |
FI89711B (fi) | 1993-07-30 |
GR3001210T3 (en) | 1992-07-30 |
CN87102891A (zh) | 1987-11-04 |
IE871012L (en) | 1987-10-17 |
JPS63107970A (ja) | 1988-05-12 |
DK184587D0 (da) | 1987-04-10 |
FI871719A0 (fi) | 1987-04-16 |
KR870010024A (ko) | 1987-11-30 |
AU602641B2 (en) | 1990-10-18 |
HK108293A (en) | 1993-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK164287A (da) | Quinolin-3-carboxylsyrederivater og fremgangsmaade til fremstilling deraf og deres anvendelse | |
DK166084C (da) | Imidazoquinolinyletherderivater og fremgangsmaade til deres fremstilling | |
NO860141L (no) | Tiazolidindionderivater og fremgangsmaate for deres fremstilling. | |
DK451887A (da) | Aryloxycarboxylsyrederivater, deres fremstilling og anvendelse | |
NO892745D0 (no) | Aminoalkylaminokarbonylaminodiolaminosyrederivater og fremgangsmaate for deres fremstilling. | |
NO882390D0 (no) | (ih-azol-1-ylmetyl)substituerte benzotriazolderivater og deres fremstilling. | |
NO871526L (no) | Tiolaktam-n-eddiksyrederivater og fremgangsmaate for deres fremstilling. | |
DK180288D0 (da) | 5-substituerede quinolon- og naphthyridoncarboxylsyrederivater, deres fremstilling og anvendelse | |
DK374289D0 (da) | Indazol-3-carboxylsyrederivater, deres fremstilling og anvendelse | |
NO875432L (no) | Sialinsyrederivater og fremgangsmaate for deres fremstilling. | |
DK605489D0 (da) | Beta-amino-boronsyre-derivater, deres fremstilling og anvendelse | |
NO870512D0 (no) | 1,4-benzoksazinderivater og fremgangsmaate for deres fremstilling. | |
DK631587D0 (da) | Imidazolderivater og fremgangsmaade til deres fremstilling | |
DK633287D0 (da) | Carbamoylimidazo-derivater, deres fremstilling og anvendelse | |
DK23687D0 (da) | Substituerede 4-amino-3-hydroxysmoersyrederivater og deres fremstilling | |
DK235787D0 (da) | Tripeptidderivater, deres fremstilling og anvendelse | |
NO883114L (no) | 1h-pyrazol-1-alkanamider og fremgangsmaate for deres fremstilling. | |
NO872625D0 (no) | Benzimidazoler og fremgangsmaater for deres fremstilling. | |
NO880606D0 (no) | Nukleotidanaloger og fremgangsmaate for deres fremstilling. | |
DK213387D0 (da) | Benzothiazinon-derivater, deres fremstilling og anvendelse | |
DK607787A (da) | 12-halogenerede forskolin-derivater, deres fremstilling og anvendelse | |
DK212687D0 (da) | Benzothiazinon-derivater, deres fremstilling og anvendelse | |
NO872885L (no) | 1,3,5-tritianderivater og fremgangsmte for deres fremstilling. | |
NO830981L (no) | Pentandionsyrederivater og fremgangsmaate for deres fremstilling. | |
NO873126D0 (no) | Cefalosporiner og derivater derav og fremgangsmaater for deres fremstilling. |